• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌 RNA 结合蛋白 Musashi1 受肿瘤抑制 miRNA 的调控。

The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.

机构信息

Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

出版信息

RNA Biol. 2011 Sep-Oct;8(5):817-28. doi: 10.4161/rna.8.5.16041. Epub 2011 Sep 1.

DOI:10.4161/rna.8.5.16041
PMID:21881409
Abstract

Musashi1 (Msi1) is an evolutionarily conserved RNA-binding protein that has been implicated in processes like stem cell fate, nervous system development, and tumorigenesis via its activities as a specific regulator of translation. While Msi1 is barely detected in normal adult tissue, it has been observed to be highly expressed in numerous tumor types (e.g. breast, colon, medulloblastoma, glioblastoma, and et cetera). Unfortunately, the molecular cues that are responsible for Msi1 upregulation in cancer cells are largely unknown. Tumor suppressor microRNAs (miRNAs) are known for targeting genes with oncogenic properties like Msi1 and for being either downregulated or deleted in tumor tissue. We observed that Msi1 long 3'UTR region is potentially targeted by several tumor suppressor miRNAs (miR-34a, -101, -128, -137, and -138). Western blotting of endogenous Msi1 protein as well as luciferase assays confirmed Msi1 regulation by these tumor suppressor miRNAs. Furthermore, we observed when examining different cellular states that these miRNAs and Msi1 have opposite expression profiles. Cell proliferation inhibition induced by the tumor suppressor miRNAs was partially rescued by Msi1 transgenic expression. We conclude that tumor suppressor miRNAs are direct and influential regulators of Msi1, affecting its expression pattern during tumorigenesis of malignant nervous system tumors.

摘要

Musashi1(Msi1)是一种进化上保守的 RNA 结合蛋白,通过作为翻译的特定调节剂的活性,它参与干细胞命运、神经系统发育和肿瘤发生等过程。虽然 Msi1 在正常成年组织中几乎检测不到,但在许多肿瘤类型(例如乳腺癌、结肠癌、髓母细胞瘤、胶质母细胞瘤等)中观察到其高度表达。不幸的是,导致癌细胞中 Msi1 上调的分子线索在很大程度上是未知的。肿瘤抑制 microRNAs(miRNAs)已知可靶向具有致癌特性的基因,如 Msi1,并在肿瘤组织中下调或缺失。我们观察到 Msi1 长 3'UTR 区域可能被几种肿瘤抑制 miRNA(miR-34a、-101、-128、-137 和 -138)靶向。内源性 Msi1 蛋白的 Western blot 以及荧光素酶测定证实了这些肿瘤抑制 miRNA 对 Msi1 的调节。此外,当我们检查不同的细胞状态时,我们观察到这些 miRNA 和 Msi1 具有相反的表达谱。肿瘤抑制 miRNA 诱导的细胞增殖抑制部分被 Msi1 转基因表达挽救。我们得出结论,肿瘤抑制 miRNA 是 Msi1 的直接和有影响力的调节剂,影响其在恶性神经系统肿瘤发生过程中的表达模式。

相似文献

1
The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.致癌 RNA 结合蛋白 Musashi1 受肿瘤抑制 miRNA 的调控。
RNA Biol. 2011 Sep-Oct;8(5):817-28. doi: 10.4161/rna.8.5.16041. Epub 2011 Sep 1.
2
The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.致癌 RNA 结合蛋白 Musashi1 通过 HuR 在神经胶质瘤细胞中的 mRNA 翻译和稳定性进行调节。
Mol Cancer Res. 2012 Jan;10(1):143-55. doi: 10.1158/1541-7786.MCR-11-0208.
3
Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development.RNA 结合蛋白 Musashi1 与 miR-137 的拮抗作用及其对神经发生和神经胶质瘤发展的潜在影响。
RNA. 2019 Jul;25(7):768-782. doi: 10.1261/rna.069211.118. Epub 2019 Apr 19.
4
Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.Musashi1通过激活Akt信号通路促进非小细胞肺癌的恶性进展和化疗耐药性。
Cell Physiol Biochem. 2017;44(2):455-466. doi: 10.1159/000485012. Epub 2017 Nov 15.
5
Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.Musashi1调节髓母细胞瘤细胞系Daoy中的细胞增殖基因。
BMC Cancer. 2008 Sep 30;8:280. doi: 10.1186/1471-2407-8-280.
6
3'-Untranslated region of doublecortin mRNA is a binding target of the Musashi1 RNA-binding protein.双皮质素信使核糖核酸的3'非翻译区是Musashi1核糖核酸结合蛋白的结合靶点。
FEBS Lett. 2009 Jul 21;583(14):2429-34. doi: 10.1016/j.febslet.2009.06.045. Epub 2009 Jun 30.
7
Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.MUSASHI1 在乳腺癌上皮细胞中的表达增加是由于 miR-125b 的下调。
BMC Mol Cell Biol. 2021 Feb 4;22(1):10. doi: 10.1186/s12860-021-00348-8.
8
Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.抑癌 microRNA-22 通过沉默 c-Myc 结合蛋白抑制 E 盒结合 c-Myc 靶基因的转录。
Oncogene. 2010 Sep 2;29(35):4980-8. doi: 10.1038/onc.2010.241. Epub 2010 Jun 21.
9
Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells.RNA 结合蛋白 Musashi1 在干细胞和癌细胞中的细胞内功能。
Stem Cell Res Ther. 2020 May 24;11(1):193. doi: 10.1186/s13287-020-01703-w.
10
miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.miR-185 靶向 RhoA 和 Cdc42 的表达并抑制人结直肠细胞的增殖潜能。
Cancer Lett. 2011 Feb 28;301(2):151-60. doi: 10.1016/j.canlet.2010.11.009. Epub 2010 Dec 24.

引用本文的文献

1
The Clinical Role of miRNAs in the Development and Treatment of Glioblastoma.微小RNA在胶质母细胞瘤发生发展及治疗中的临床作用
Int J Mol Sci. 2025 Mar 18;26(6):2723. doi: 10.3390/ijms26062723.
2
Fetal Brain-Derived Exosomal miRNAs from Maternal Blood: Potential Diagnostic Biomarkers for Fetal Alcohol Spectrum Disorders (FASDs).胎儿血源性外泌体 miRNAs 作为胎儿酒精谱系障碍(FASDs)的潜在诊断生物标志物。
Int J Mol Sci. 2024 May 27;25(11):5826. doi: 10.3390/ijms25115826.
3
Glioblastoma Therapy: Past, Present and Future.胶质母细胞瘤治疗:过去、现在和未来。
Int J Mol Sci. 2024 Feb 21;25(5):2529. doi: 10.3390/ijms25052529.
4
Post-transcriptional mechanisms controlling neurogenesis and direct neuronal reprogramming.控制神经发生和直接神经元重编程的转录后机制。
Neural Regen Res. 2024 Sep 1;19(9):1929-1939. doi: 10.4103/1673-5374.390976. Epub 2023 Dec 15.
5
Engineered smart materials for RNA based molecular therapy to treat Glioblastoma.用于基于RNA的分子疗法治疗胶质母细胞瘤的工程智能材料。
Bioact Mater. 2023 Nov 27;33:396-423. doi: 10.1016/j.bioactmat.2023.11.007. eCollection 2024 Mar.
6
miR-671-5p Inhibition by MSI1 Promotes Glioblastoma Tumorigenesis via Radioresistance, Tumor Motility and Cancer Stem-like Cell Properties.MSI1对miR-671-5p的抑制通过放射抗性、肿瘤运动性和癌症干细胞样特性促进胶质母细胞瘤的肿瘤发生。
Biomedicines. 2021 Dec 23;10(1):21. doi: 10.3390/biomedicines10010021.
7
DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer.双皮质素样激酶1(DCLK1)及其相互作用蛋白:结直肠癌的有效治疗靶点。
Oncol Lett. 2021 Dec;22(6):850. doi: 10.3892/ol.2021.13111. Epub 2021 Oct 26.
8
Role of microRNAs in glioblastoma.微小RNA在胶质母细胞瘤中的作用。
Oncotarget. 2021 Aug 17;12(17):1707-1723. doi: 10.18632/oncotarget.28039.
9
Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway.Msi1 通过调节细胞外基质降解的侵袭伪足来促进乳腺癌转移,该过程是通过 Timp3-Mmp9 通路实现的。
Oncogene. 2021 Jul;40(29):4832-4845. doi: 10.1038/s41388-021-01873-8. Epub 2021 Jun 21.
10
Musashi-1-A Stemness RBP for Cancer Therapy?Musashi-1——一种用于癌症治疗的干性RNA结合蛋白?
Biology (Basel). 2021 May 5;10(5):407. doi: 10.3390/biology10050407.